Optimal treatment strategies for stage I non-small cell lung cancer in veterans with pulmonary and cardiac comorbidities
暂无分享,去创建一个
Sadiq S. Rehmani | S. Bates | M. Gould | C. Kong | K. Sigel | J. Wisnivesky | M. Kale | F. Bhora | K. Crothers | K. Stone | Y. Park
[1] S. Force,et al. Community Size and Lung Cancer Resection Outcomes: Studying the Society of Thoracic Surgery Database. , 2020, The Annals of thoracic surgery.
[2] anonymous,et al. Comprehensive review , 2019 .
[3] B. Meyers,et al. Surgical Resection Versus Stereotactic Body Radiation Therapy for Stage I NSCLC: Can Randomized Trials Provide the Solution? , 2018, Cancers.
[4] C. Kelsey,et al. Surgery versus stereotactic body radiation therapy for stage I non–small cell lung cancer: A comprehensive review , 2018, Cancer.
[5] James D. Murphy,et al. Stereotactic Body Radiation Therapy Versus Surgery for Early Lung Cancer Among US Veterans. , 2018, The Annals of thoracic surgery.
[6] H. Decaluwé,et al. Coronary artery disease is associated with an increased mortality rate following video‐assisted thoracoscopic lobectomy , 2017, The Journal of thoracic and cardiovascular surgery.
[7] M. Berry,et al. A Risk Score to Assist Selecting Lobectomy Versus Sublobar Resection for Early Stage Non-Small Cell Lung Cancer. , 2016, The Annals of thoracic surgery.
[8] M. Okumura,et al. Outcomes of lung cancer surgery in patients with coronary artery disease: a decade of experience at a single institution , 2016, Surgery Today.
[9] S. Ramalingam,et al. Survival After Sublobar Resection versus Lobectomy for Clinical Stage IA Lung Cancer: An Analysis from the National Cancer Data Base , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[10] K. Rosenzweig,et al. Outcomes after Stereotactic Body Radiotherapy versus Limited Resection in Older Patients with Early-Stage Lung Cancer , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[11] Joe Y. Chang,et al. Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly. , 2014, JAMA surgery.
[12] R. Wiener. Balancing the Benefits and Harms of Low-Dose Computed Tomography Screening for Lung Cancer: Medicare's Options for Coverage , 2014, Annals of Internal Medicine.
[13] L. Ellis,et al. American Society of Clinical Oncology perspective: Raising the bar for clinical trials by defining clinically meaningful outcomes. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] J. Kestle. Clinical Trials , 2014, World Journal of Surgery.
[15] N. Tanner,et al. Attitudes and beliefs toward lung cancer screening among US Veterans. , 2013, Chest.
[16] Alessandro Brunelli,et al. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. , 2013, Chest.
[17] Jeffrey D Bradley,et al. Patterns of Failure after Stereotactic Body Radiation Therapy or Lobar Resection for Clinical Stage I Non–Small-Cell Lung Cancer , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[18] G Scott Gazelle,et al. Chapter 9: The MGH‐HMS Lung Cancer Policy Model: Tobacco Control Versus Screening , 2012, Risk analysis : an official publication of the Society for Risk Analysis.
[19] M. Kelley,et al. Cancer incidence among patients of the U.S. Veterans Affairs Health Care System. , 2012, Military medicine.
[20] U. Sartipy,et al. Predictors of Postoperative Quality of Life after Surgery for Lung Cancer , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[21] M. Scarci,et al. Are we treating enough elderly patients with early stage non-small cell lung cancer? , 2011, Lung cancer.
[22] M. Decamp,et al. Lung cancer in chronic obstructive pulmonary disease: enhancing surgical options and outcomes. , 2011, American journal of respiratory and critical care medicine.
[23] S. Swanson,et al. Survival following lobectomy and limited resection for the treatment of stage I non-small cell lung cancer<=1 cm in size: a review of SEER data. , 2011, Chest.
[24] P. Lambin,et al. Health-related quality of life in patients surviving non-small cell lung cancer , 2010, Thorax.
[25] E. Halm,et al. Limited Resection for the Treatment of Patients With Stage IA Lung Cancer , 2010, Annals of surgery.
[26] J. Hanmer. Predicting an SF-6D preference-based score using MCS and PCS scores from the SF-12 or SF-36. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[27] P. Metcalf,et al. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history , 2009, European Respiratory Journal.
[28] Sheldon Brown,et al. Veterans Aging Cohort Study (VACS): Overview and Description , 2006, Medical care.
[29] M. Simon,et al. Predictors of enrollment in lung cancer clinical trials , 2006, Cancer.
[30] M. Iannuzzi,et al. Radiation therapy for the treatment of unresected stage I-II non-small cell lung cancer. , 2005, Chest.
[31] B. Gage,et al. Accuracy of ICD-9-CM Codes for Identifying Cardiovascular and Stroke Risk Factors , 2005, Medical care.
[32] G. Byrnes,et al. Surgery for early stage non-small cell lung cancer. , 2004, The Cochrane database of systematic reviews.
[33] S. Gürsoy,et al. Outcome of Surgery for Lung Cancer in Young and Elderly Patients , 2004, Surgery Today.
[34] J. Coebergh,et al. Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population-based study. , 1998, Lung cancer.
[35] H. Wada,et al. Thirty-day operative mortality for thoracotomy in lung cancer. , 1998, The Journal of thoracic and cardiovascular surgery.
[36] R. Feins. Surgery for early stage non-small cell lung cancer. , 1997, Seminars in oncology.
[37] T. Carmody,et al. Comparing the smoking behavior of veterans and nonveterans. , 1997, Public health reports.
[38] M. Mack,et al. Wedge resection versus lobectomy for stage I (T1 N0 M0) non-small-cell lung cancer. , 1997, The Journal of thoracic and cardiovascular surgery.
[39] L V Rubinstein,et al. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. , 1995, The Annals of thoracic surgery.
[40] E. Wynder,et al. Cancer risk in male veterans utilizing the veterans administration medical system , 1989, Cancer.